Arcutis Biotherapeutics Inc banner

Arcutis Biotherapeutics Inc
NASDAQ:ARQT

Watchlist Manager
Arcutis Biotherapeutics Inc Logo
Arcutis Biotherapeutics Inc
NASDAQ:ARQT
Watchlist
Price: 21.46 USD 0.09% Market Closed
Market Cap: $2.7B

Wall St Price Targets

ARQT Price Targets Summary
Arcutis Biotherapeutics Inc

Wall Street analysts forecast ARQT stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for ARQT is 35.32 USD with a low forecast of 33.33 USD and a high forecast of 37.8 USD.

Lowest Forecast
Price Target
33.33 USD
55% Upside
Average Forecast
Price Target
35.32 USD
65% Upside
Highest Forecast
Price Target
37.8 USD
76% Upside
Arcutis Biotherapeutics Inc Competitors:
Price Targets
1981
Cathay Media and Education Group Inc
50% Upside
BTBT
Bit Digital Inc
156% Upside
BRI
Britania PCL
15% Upside
VRNS
Varonis Systems Inc
5% Upside
ACAD
ACADIA Pharmaceuticals Inc
48% Upside
DXPE
DXP Enterprises Inc
0% Upside

Revenue
Forecast

N/A
Past Growth
18% / Year
Estimated Growth
Estimates Accuracy
3%
Average Beat
N/A
Past Growth
18% / Year
Estimated Growth
Estimates Accuracy
3%
Average Beat

The compound annual growth rate for Revenue over the next 8 years is 18%.

Operating Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-6%
Average Miss
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-6%
Average Miss

Net Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-58%
Average Miss
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-58%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is ARQT's stock price target?
Price Target
35.32 USD

According to Wall Street analysts, the average 1-year price target for ARQT is 35.32 USD with a low forecast of 33.33 USD and a high forecast of 37.8 USD.

What is the Revenue forecast for Arcutis Biotherapeutics Inc?
Projected CAGR
18%

The compound annual growth rate for Revenue over the next 8 years is 18%.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett